These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33371850)

  • 1. Patients with Rheumatic Diseases Overlooked during COVID-19 Pandemic: How are They Doing and Behaving?
    Adnine A; Soussan I; Nadiri K; Coulibaly S; Berrada K; Najdi A; Abourazzak FE
    Curr Rheumatol Rev; 2021 Aug; 17(3):318-326. PubMed ID: 33371850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020.
    Richez C; Flipo RM; Berenbaum F; Cantagrel A; Claudepierre P; Debiais F; Dieudé P; Goupille P; Roux C; Schaeverbeke T; Wendling D; Pham T; Thomas T
    Joint Bone Spine; 2020 Oct; 87(5):431-437. PubMed ID: 32473418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mental Health Problems Experienced by Patients with Rheumatic Diseases During COVID-19 Pandemic.
    Adnine A; Nadiri K; Soussan I; Coulibaly S; Berrada K; Najdi A; Abourazzak FE
    Curr Rheumatol Rev; 2021; 17(3):303-311. PubMed ID: 33504309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry.
    Glintborg B; Jensen DV; Engel S; Terslev L; Pfeiffer Jensen M; Hendricks O; Ostergaard M; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Agerbo J; Ziegler C; Hetland M
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33402443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of COVID-19 pandemic on patients with rheumatic diseases in Latin America.
    Fernández-Ávila DG; Barahona-Correa J; Romero-Alvernia D; Kowalski S; Sapag A; Cachafeiro-Vilar A; Meléndez B; Pastelín C; Palleiro D; Arrieta D; Reyes G; Pons-Estel GJ; Then-Báez J; Ugarte-Gil MF; Cardiel MH; Colman N; Chávez N; Burgos PI; Montufar R; Sandino S; Fuentes-Silva YJ; Soriano ER
    Rheumatol Int; 2022 Jan; 42(1):41-49. PubMed ID: 34739574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries.
    Dejaco C; Alunno A; Bijlsma JW; Boonen A; Combe B; Finckh A; Machado PM; Padjen I; Sivera F; Stamm TA; Buttgereit F
    Ann Rheum Dis; 2021 Apr; 80(4):518-526. PubMed ID: 33158877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of patients with rheumatic and musculoskeletal diseases during the coronavirus disease 2019 pandemic and the association of its relapse with infection: Across-sectional study.
    Zhang Y; Xu P; Huang J; Hu Z
    Int J Rheum Dis; 2024 Apr; 27(4):e15150. PubMed ID: 38661306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modifications in Systemic Rheumatic Disease Medications: Patients' Perspectives During the Height of the COVID-19 Pandemic in New York City.
    Mancuso CA; Duculan R; Jannat-Khah D; Barbhaiya M; Bass AR; Mandl LA; Mehta B
    Arthritis Care Res (Hoboken); 2021 Jun; 73(6):909-917. PubMed ID: 33085850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of Covid-19 in patients with rheumatic diseases and the effects of the pandemic on rheumatology outpatient care: A single-centre experience from Turkey.
    Batıbay S; Koçak Ulucaköy R; Özdemir B; Günendi Z; Göğüş FN
    Int J Clin Pract; 2021 Sep; 75(9):e14442. PubMed ID: 34105856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A cross sectional study on patients with inflammatory rheumatic diseases in terms of their compliance to their immunsuppressive medication during COVID-19 pandemic].
    Schmeiser T; Broll M; Dormann A; Fräbel C; Hermann W; Hudowenz O; Keil F; Müller-Ladner U; Özden F; Pfeiffer U; Saech J; Schwarting A; Stapfer G; Steinchen N; Storck-Müller K; Strunk J; Thiele A; Triantafyllias K; Wassenberg S; Wilden E; Hasseli R
    Z Rheumatol; 2020 May; 79(4):379-384. PubMed ID: 32303821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
    Santos CS; Férnandez XC; Moriano Morales C; Álvarez ED; Álvarez Castro C; López Robles A; Pérez Sandoval T
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33455920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.
    Michelena X; Borrell H; López-Corbeto M; López-Lasanta M; Moreno E; Pascual-Pastor M; Erra A; Serrat M; Espartal E; Antón S; Añez GA; Caparrós-Ruiz R; Pluma A; Trallero-Araguás E; Barceló-Bru M; Almirall M; De Agustín JJ; Lladós J; Julià A; Marsal S
    Semin Arthritis Rheum; 2020 Aug; 50(4):564-570. PubMed ID: 32425260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of COVID-19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data?
    Favalli EG; Monti S; Ingegnoli F; Balduzzi S; Caporali R; Montecucco C
    Arthritis Rheumatol; 2020 Oct; 72(10):1600-1606. PubMed ID: 32506699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the COVID-19 Pandemic on the Employment of Canadian Young Adults With Rheumatic Disease: Findings From a Longitudinal Survey.
    Jetha A; Tucker LB; Chen C; Gignac MAM
    Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1146-1152. PubMed ID: 33973377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Rheumatic Diseases During the COVID-19 Pandemic: A National Veterans Affairs Survey of Rheumatologists.
    Singh JA; Richards JS; Chang E; Joseph A; Ng B
    Arthritis Care Res (Hoboken); 2021 Jul; 73(7):998-1003. PubMed ID: 33058485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of coronavirus disease 2019 in rheumatic patients and evaluation of the effect of disease-modifying anti-rheumatic drugs.
    Moradi S; Masoumi M; Mohammadi S; Vafaeimanesh J; Mohseni M; Mahdavi H; Aryannejad A
    Intern Emerg Med; 2021 Jun; 16(4):919-923. PubMed ID: 33128696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemic.
    Tam LS; Tanaka Y; Handa R; Li Z; Lorenzo JP; Louthrenoo W; Hill C; Pile K; Robinson PC; Dans LF; Hsu LY; Lee SM; Cho J; Hasan ATMT; Salim B; Samreen S; Shaharir SS; Wong P; Chau J; Danda D; Haq SA
    Int J Rheum Dis; 2021 Jun; 24(6):733-745. PubMed ID: 33945214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry.
    Kihara M; Sugihara T; Asano J; Sato M; Kaneko H; Muraoka S; Ohshima S; Nanki T
    Clin Rheumatol; 2022 Dec; 41(12):3661-3673. PubMed ID: 35974224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 in French patients with chronic inflammatory rheumatic diseases: Clinical features, risk factors and treatment adherence.
    Costantino F; Bahier L; Tarancón LC; Leboime A; Vidal F; Bessalah L; Breban M; D'Agostino MA
    Joint Bone Spine; 2021 Jan; 88(1):105095. PubMed ID: 33152484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance Registry.
    Yazdany J; Ware A; Wallace ZS; Bhana S; Grainger R; Hachulla E; Richez C; Cacoub P; Hausmann JS; Liew JW; Sirotich E; Jacobsohn L; Strangfeld A; Mateus EF; Hyrich KL; Gossec L; Carmona L; Lawson-Tovey S; Kearsley-Fleet L; Schaefer M; Ribeiro SLE; Al-Emadi S; Hasseli R; Müller-Ladner U; Specker C; Schulze-Koops H; Bernardes M; Fraga VM; Rodrigues AM; Sparks JA; Ljung L; Di Giuseppe D; Tidblad L; Wise L; Duarte-García A; Ugarte-Gil MF; Colunga-Pedraza IJ; Martínez-Martínez MU; Alpizar-Rodriguez D; Xavier RM; Isnardi CA; Pera M; Pons-Estel G; Izadi Z; Gianfrancesco MA; Carrara G; Scirè CA; Zanetti A; Machado PM
    Arthritis Care Res (Hoboken); 2024 Feb; 76(2):274-287. PubMed ID: 37643903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.